Dovitinib

A benzimidazole-quinolinone compound and receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Dovitinib binds to and inhibits the phosphorylation of type III-V RTKs, such as vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) that promote tumor cell proliferation and survival in certain cancer cells. In addition, this agent also inhibits other members of the RTK superfamily, including fibroblast growth factor receptor 1 and 3, FMS-like tyrosine kinase 3, stem cell factor receptor (c-KIT), and colony stimulating factor receptor 1. This may further lead to a reduction of cellular proliferation and angiogenesis, and an induction of tumor cell apoptosis. (NCI Thesaurus)

YOU MAY ALSO LIKE

Douche Solution Dosage Form

A solution intended for use as a vaginal irrigant.

Douche Powder Dosage Form

A powder which may be mixed with a liquid, intended for administration as a vaginal irrigant.

Douche Dosage Form

A substance intended for use as a vaginal irrigant.

Douche

A procedure in which the vagina is washed with water or a cleansing solution. Most cleansing solutions contain water mixed with vinegar,…

Doubling time

In biology, the amount of time it takes for one cell to divide or for a group of cells (such as a…

Doublesex- and Mab-3-Related Transcription Factor 1

Doublesex- and mab-3-related transcription factor 1 (373 aa, ~39 kDa) is encoded by the human DMRT1 gene. This protein plays a role…